Metropolitan Life Insurance CO Ngm Biopharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

$253 Million
Q2 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $543 - $788	-146 Reduced 6.1%	2,246 $9,000
Q4 2022 Jun 14, 2023	BUY	$3.41 - $12.93 $497 - $1,887	146 Added 6.5%	2,392 $12 Million
Q3 2022 Jun 14, 2023	BUY	$12.59 - $17.67 $1,838 - $2,579	146 Added 6.5%	2,392 $31.3 Million
Q2 2022 Jun 20, 2023	BUY	$10.58 - $17.5 $1,544 - $2,555	146 Added 6.5%	2,392 $30,000
Q2 2022 Mar 30, 2023	BUY	$10.58 - $17.5 $7,014 - $11,602	663 Added 38.35%	2,392 $30,000
Q2 2022 Aug 11, 2022	BUY	$10.58 - $17.5 $7,014 - $11,602	663 Added 38.35%	2,392 $31,000
Q1 2022 Jun 20, 2023	SELL	$13.81 - $18.6 $7,139 - $9,616	-517 Reduced 23.02%	1,729 $26,000
Q1 2022 Mar 30, 2023	SELL	$13.81 - $18.6 $103,961 - $140,020	-7,528 Reduced 81.32%	1,729 $26,000
Q1 2022 May 12, 2022	SELL	$13.81 - $18.6 $103,961 - $140,020	-7,528 Reduced 81.32%	1,729 $26,000
Q4 2021 Jun 21, 2023	BUY	$17.26 - $22.02 $121,009 - $154,382	7,011 Added 312.15%	9,257 $163,000
Q3 2021 Jun 21, 2023	BUY	$20.15 - $26.19 $141,271 - $183,618	7,011 Added 312.15%	9,257 $194,000
Q2 2021 Jun 21, 2023	BUY	$15.06 - $30.03 $105,585 - $210,540	7,011 Added 312.15%	9,257 $182,000
Q2 2021 Mar 30, 2023	BUY	$15.06 - $30.03 $16,716 - $33,333	1,110 Added 13.62%	9,257 $182,000
Q2 2021 Aug 16, 2021	BUY	$15.06 - $30.03 $139,289 - $277,747	9,249 Added 115612.5%	9,257 $183,000
Q1 2021 Jun 26, 2023	BUY	$24.99 - $31.93 $147,465 - $188,418	5,901 Added 262.73%	8,147 $237 Million
Q1 2021 Mar 30, 2023	SELL	$24.99 - $31.93 $4,848 - $6,194	-194 Reduced 2.33%	8,147 $236,000
Q1 2021 May 14, 2021	SELL	$24.99 - $31.93 $208,241 - $266,072	-8,333 Reduced 99.9%	8 $237,000
Q4 2020 Jun 22, 2023	BUY	$16.21 - $31.44 $98,799 - $191,626	6,095 Added 271.37%	8,341 $252,000
Q3 2020 Jun 26, 2023	BUY	$15.59 - $19.97 $95,021 - $121,717	6,095 Added 271.37%	8,341 $132,000
Q2 2020 Jun 26, 2023	BUY	$11.97 - $23.47 $72,957 - $143,049	6,095 Added 271.37%	8,341 $164,000
Q1 2020 Jul 12, 2023	BUY	$10.0 - $19.51 $60,950 - $118,913	6,095 Added 271.37%	8,341 $102,000
Q4 2019 Jul 12, 2023	BUY	$9.97 - $20.28 $60,767 - $123,606	6,095 Added 271.37%	8,341 $154,000
Q4 2019 Mar 30, 2023	BUY	$9.97 - $20.28 $59,311 - $120,645	5,949 Added 248.7%	8,341 $154,000
Q4 2019 Feb 14, 2020	BUY	$9.97 - $20.28 $83,159 - $169,155	8,341 New	8,341 $154,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account